Amgen's $10B Onyx Buy Takes Training Wheels Off 251(h)
Amgen Inc. is using the new Delaware tender offer law for its $10.4 billion acquisition of Onyx Pharmaceuticals Inc., but seems more confident that there won't be any hiccups, foregoing fallbacks...To view the full article, register now.
Already a subscriber? Click here to view full article